Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

Pier Luigi Almasio, Massimo Colombo, Stephen A. Harrison, Samuel S. Lee, Mahmoud A. Khattab, Stephanos J. Hadziyannis, Ayman A. Abdo, Mohammed Eslam, Nazir Ibrahim, Michael P. Manns, Rafael Esteban, Patrice Cacoub, Peter Ferenci

Risultato della ricerca: Article

104 Citazioni (Scopus)

Abstract

HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections.
Lingua originaleEnglish
Numero di pagine13
RivistaJournal of Hepatology
Volume54
Stato di pubblicazionePublished - 2011

Fingerprint

Hepacivirus
Genotype
Eastern Africa
Middle East
Chronic Hepatitis C
Chronic Hepatitis
North America
Infection
Natural History
Liver Transplantation
Hepatocellular Carcinoma
Epidemiology
Fibrosis
Therapeutics
Research

All Science Journal Classification (ASJC) codes

  • Hepatology

Cita questo

Almasio, P. L., Colombo, M., Harrison, S. A., Lee, S. S., Khattab, M. A., Hadziyannis, S. J., ... Ferenci, P. (2011). Management of hepatitis C virus genotype 4: recommendations of an international expert panel. Journal of Hepatology, 54.

Management of hepatitis C virus genotype 4: recommendations of an international expert panel. / Almasio, Pier Luigi; Colombo, Massimo; Harrison, Stephen A.; Lee, Samuel S.; Khattab, Mahmoud A.; Hadziyannis, Stephanos J.; Abdo, Ayman A.; Eslam, Mohammed; Ibrahim, Nazir; Manns, Michael P.; Esteban, Rafael; Cacoub, Patrice; Ferenci, Peter.

In: Journal of Hepatology, Vol. 54, 2011.

Risultato della ricerca: Article

Almasio, PL, Colombo, M, Harrison, SA, Lee, SS, Khattab, MA, Hadziyannis, SJ, Abdo, AA, Eslam, M, Ibrahim, N, Manns, MP, Esteban, R, Cacoub, P & Ferenci, P 2011, 'Management of hepatitis C virus genotype 4: recommendations of an international expert panel.', Journal of Hepatology, vol. 54.
Almasio, Pier Luigi ; Colombo, Massimo ; Harrison, Stephen A. ; Lee, Samuel S. ; Khattab, Mahmoud A. ; Hadziyannis, Stephanos J. ; Abdo, Ayman A. ; Eslam, Mohammed ; Ibrahim, Nazir ; Manns, Michael P. ; Esteban, Rafael ; Cacoub, Patrice ; Ferenci, Peter. / Management of hepatitis C virus genotype 4: recommendations of an international expert panel. In: Journal of Hepatology. 2011 ; Vol. 54.
@article{e006084ce2d9486d94d9f9f92a5e0de1,
title = "Management of hepatitis C virus genotype 4: recommendations of an international expert panel.",
abstract = "HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80{\%} of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20{\%} of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections.",
author = "Almasio, {Pier Luigi} and Massimo Colombo and Harrison, {Stephen A.} and Lee, {Samuel S.} and Khattab, {Mahmoud A.} and Hadziyannis, {Stephanos J.} and Abdo, {Ayman A.} and Mohammed Eslam and Nazir Ibrahim and Manns, {Michael P.} and Rafael Esteban and Patrice Cacoub and Peter Ferenci",
year = "2011",
language = "English",
volume = "54",
journal = "Journal of Hepatology",
issn = "0168-8278",
publisher = "Elsevier",

}

TY - JOUR

T1 - Management of hepatitis C virus genotype 4: recommendations of an international expert panel.

AU - Almasio, Pier Luigi

AU - Colombo, Massimo

AU - Harrison, Stephen A.

AU - Lee, Samuel S.

AU - Khattab, Mahmoud A.

AU - Hadziyannis, Stephanos J.

AU - Abdo, Ayman A.

AU - Eslam, Mohammed

AU - Ibrahim, Nazir

AU - Manns, Michael P.

AU - Esteban, Rafael

AU - Cacoub, Patrice

AU - Ferenci, Peter

PY - 2011

Y1 - 2011

N2 - HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections.

AB - HCV has been classified into no fewer than six major genotypes and a series of subtypes. Each HCV genotype is unique with respect to its nucleotide sequence, geographic distribution, and response to therapy. Genotypes 1, 2, and 3 are common throughout North America and Europe. HCV genotype 4 (HCV-4) is common in the Middle East and in Africa, where it is responsible for more than 80% of HCV infections. It has recently spread to several European countries. HCV-4 is considered a major cause of chronic hepatitis, cirrhosis, hepatocellular carcinoma, and liver transplantation in these regions. Although HCV-4 is the cause of approximately 20% of the 170 million cases of chronic hepatitis C in the world, it has not been the subject of widespread research. Therefore, this document, drafted by a panel of international experts, aimed to review current knowledge on the epidemiology, natural history, clinical, histological features, and treatment of HCV-4 infections.

UR - http://hdl.handle.net/10447/81110

M3 - Article

VL - 54

JO - Journal of Hepatology

JF - Journal of Hepatology

SN - 0168-8278

ER -